NIAGEN BIOSCIENCE, INC. Current Federal, State and Local, Tax Expense (Benefit)
NIAGEN BIOSCIENCE, INC. (NAGE) reported Current Federal, State and Local, Tax Expense (Benefit) of $305.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit · last filed 2025-03-04
- NIAGEN BIOSCIENCE, INC. current federal, state and local, tax expense (benefit) for fiscal 2024 was $305.00K.
- NIAGEN BIOSCIENCE, INC. current federal, state and local, tax expense (benefit) for fiscal 2023 was $0.00.
| Period end | Current Federal, State and Local, Tax Expense (Benefit) 12 month |
|---|---|
| 2024-12-31 | $305.00K 10-K · filed 2025-03-04 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |